Biocompatibility and nanostructured materials: applications in nanomedicine

References

• Adabi M, Saber R, Adabi M, Sarkar S. 2011. Examination of incubation time of bare gold electrode inside cysteamine solution for immobilization of multi-walled carbon nanotubes on a gold electrode modified with cysteamine. Microchim Acta. 172:83–88.
   Web of Science ®Google Scholar
• Adabi M, Saber R, Faridi-Majidi R, Faridbod F. 2015a. Performance of electrodes synthesized with polyacrylonitrile-based carbon nanofibers for application in electrochemical sensors and biosensors. Mater Sci Eng C. 48:673–678.
   PubMed Web of Science ®Google Scholar
• Adabi M, Saber R, Naghibzadeh M, Faridbod F, Faridi-Majidi R. 2015b. Parameters affecting carbon nanofiber electrodes for measurement of cathodic current in electrochemical sensors: an investigation using artificial neural network. RSC Adv. 5:81243–81252.
   Web of Science ®Google Scholar
• Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE. 2009. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev. 61:428–437.
   PubMed Web of Science ®Google Scholar
• Ai J, Biazar E, Jafarpour M, Montazeri M, Majdi A, Aminifard S, et al. 2011. Nanotoxicology and nanoparticle safety in biomedical designs. Int J Nanomedicine. 6:1117–1127.
   PubMedGoogle Scholar
• Arsianti M, Lim M, Lou SN, Goon IY, Marquis CP, Amal R. 2011. Bi-functional gold-coated magnetite composites with improved biocompatibility. J Colloid Interface Sci. 354:536–545.
   PubMed Web of Science ®Google Scholar
• Arsianti M, Lim M, Marquis CP, Amal R. 2010. Polyethylenimine based magnetic iron-oxide vector: the effect of vector component assembly on cellular entry mechanism, intracellular localization, and cellular viability. Biomacromolecules. 11:2521–2531.
   PubMed Web of Science ®Google Scholar
• Barrett EG, Johnston C, Oberdörster G, Finkelstein JN. 1999. Silica binds serum proteins resulting in a shift of the dose-response for silica-induced chemokine expression in an alveolar type II cell line. Toxicol Appl Pharmacol. 161:111–122.
   PubMed Web of Science ®Google Scholar
• Begley DJ. 1996. The blood-brain barrier: principles for targeting peptides and drugs to the central nervous system. J Pharm Pharmacol. 48:136–146.
   PubMed Web of Science ®Google Scholar
• Begley DJ. 2004. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Pharmacol Ther. 104:29–45.
   PubMed Web of Science ®Google Scholar
• Bleeker EA, de Jong WH, Geertsma RE, Groenewold M, Heugens EH, Koers-Jacquemijns M, et al. 2012. Considerations on the EU definition of a nanomaterial: science to support policy making. Regul Toxicol Pharmacol. 65:119–125.
   PubMed Web of Science ®Google Scholar
• Braydich-Stolle LK, Schaeublin NM, Murdock RC, Jiang J, Biswas P, Schlager JJ, Hussain SM. 2009. Crystal structure mediates mode of cell death in TiO2 nanotoxicity. J Nanopart Res. 11:1361–1374.
   Web of Science ®Google Scholar
• Brown SC, Kamal M, Nasreen N, Baumuratov A, Sharma P, Antony VB, Moudgil BM. 2007. Influence of shape, adhesion and simulated lung mechanics on amorphous silica nanoparticle toxicity. Adv Powder Technol. 18:69–80.
   Web of Science ®Google Scholar
• Cai K, Yao K, Cui Y, Yang Z, Li X, Xie H, Qing T, Gao L. 2002. Influence of different surface modification treatments on poly(D,L-lactic acid) with silk fibroin and their effects on the culture of osteoblast in vitro. Biomaterials. 23:1603–1611.
   PubMed Web of Science ®Google Scholar
• Campoccia D, Arciola CR, Cervellati M, Maltarello MC, Montanaro L. 2003. In vitro behaviour of bone marrow-derived mesenchymal cells cultured on fluorohydroxyapatite-coated substrata with different roughness. Biomaterials. 24:587–596.
   PubMed Web of Science ®Google Scholar
• Carrstensen H, Müller R, Müller B. 1992. Particle size, surface hydrophobicity and interaction with serum of parenteral fat emulsions and model drug carriers as parameters related to RES uptake. Clin Nutr. 11:289–297.
   PubMed Web of Science ®Google Scholar
• Cartiera MS, Johnson KM, Rajendran V, Caplan MJ, Saltzman WM. 2009. The uptake and intracellular fate of PLGA nanoparticles in epithelial cells. Biomaterials. 30:2790–2798.
   PubMed Web of Science ®Google Scholar
• Cattel L, Ceruti M, Dosio F. 2002. From conventional to stealth liposomes: a new frontier in cancer chemotherapy. Tumori. 89:237–249.
   Web of Science ®Google Scholar
• Cedervall T, Lynch I, Foy M, Berggard T, Donnelly SC, Cagney G, Linse S, Dawson KA. 2007a. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew Chem Int Ed Engl. 46:5754–5756.
   PubMed Web of Science ®Google Scholar
• Cedervall T, Lynch I, Lindman S, Berggård T, Thulin E, Nilsson H, Dawson KA, Linse S. 2007b. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci USA. 104:2050–2055.
   PubMed Web of Science ®Google Scholar
• Chang TMS. 2014. Artificial cells: the beginning of nanomedicine. Select Top Nanomedicine. 3:1–44.
   Google Scholar
• Chen L, McCrate JM, Lee JC, Li H. 2011. The role of surface charge on the uptake and biocompatibility of hydroxyapatite nanoparticles with osteoblast cells. Nanotechnology. 22:105708. doi(2011 Feb 2):10.1088/0957-4484/22/10/105708.
   PubMed Web of Science ®Google Scholar
• Chen Y-S, Hung Y-C, Liau I, Huang GS. 2009. Assessment of the in vivo toxicity of gold nanoparticles. Nanoscale Res Lett. 4:858–864.
   PubMed Web of Science ®Google Scholar
• Chithrani BD, Ghazani AA, Chan WC. 2006. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 6:662–668.
   PubMed Web of Science ®Google Scholar
• Chonn A, Semple S, Cullis P. 1992. Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes. J Biol Chem. 267:18759–18765.
   PubMed Web of Science ®Google Scholar
• Chou L, Marek B, Wagner W. 1999. Effects of hydroxylapatite coating crystallinity on biosolubility, cell attachment efficiency and proliferation in vitro. Biomaterials. 20:977–985.
   PubMed Web of Science ®Google Scholar
• Cordon-Cardo C, O'Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR, Bertino JR. 1989. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA. 86:695–698.
   PubMed Web of Science ®Google Scholar
• Cristina Yeber M, Rodrı´guez J, Freer J, Durán N, Mansilla DH. 2000. Photocatalytic degradation of cellulose bleaching effluent by supported TiO2 and ZnO. Chemosphere. 41:1193–1197.
   PubMed Web of Science ®Google Scholar
• De Jong WH, Hagens WI, Krystek P, Burger MC, Sips AJ, Geertsma RE. 2008. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials. 29:1912–1919.
   PubMed Web of Science ®Google Scholar
• Decuzzi P, Pasqualini R, Arap W, Ferrari M. 2009. Intravascular delivery of particulate systems: does geometry really matter? Pharm Res. 26:235–243.
   PubMed Web of Science ®Google Scholar
• Dhawan A, Sharma V. 2010. Toxicity assessment of nanomaterials: methods and challenges. Anal Bioanal Chem. 398:589–605.
   PubMed Web of Science ®Google Scholar
• Dobrovolskaia MA, Aggarwal P, Hall JB, McNeil SE. 2008. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharmaceut. 5:487–495.
   PubMed Web of Science ®Google Scholar
• Dobrovolskaia MA, McNeil SE. 2007. Immunological properties of engineered nanomaterials. Nat Nanotechnol. 2:469–478.
   PubMed Web of Science ®Google Scholar
• Donaldson K, Stone V, Clouter A, Renwick L, MacNee W. 2001. Ultrafine particles. Occup Environ Med. 58:211–216.
   PubMed Web of Science ®Google Scholar
• Duncan R, Izzo L. 2005. Dendrimer biocompatibility and toxicity. Adv Drug Deliv Rev. 57:2215–2237.
   PubMed Web of Science ®Google Scholar
• Engel E, Michiardi A, Navarro M, Lacroix D, Planell JA. 2008. Nanotechnology in regenerative medicine: the materials side. Trends Biotechnol. 26:39–47.
   PubMed Web of Science ®Google Scholar
• Fadeel B, Garcia-Bennett AE. 2010. Better safe than sorry: understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. Adv Drug Deliv Rev. 62:362–374.
   PubMed Web of Science ®Google Scholar
• Foldvari M, Bagonluri M. 2008. Carbon nanotubes as functional excipients for nanomedicines: II. Drug delivery and biocompatibility issues. Nanomed Nanotechnol. 4:183–200.
   PubMed Web of Science ®Google Scholar
• Fubini B, Hubbard A. 2003. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis. Free Radic Biol Med. 34:1507–1516.
   PubMed Web of Science ®Google Scholar
• Gatti AM, Rivasi F. 2002. Biocompatibility of micro- and nanoparticles. Part I: in liver and kidney. Biomaterials. 23:2381–2387.
   PubMed Web of Science ®Google Scholar
• Gaumet M, Vargas A, Gurny R, Delie F. 2008. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur J Pharm Biopharm. 69:1–9.
   PubMed Web of Science ®Google Scholar
• Geiser M, Rothen-Rutishauser B, Kapp N, Schürch S, Kreyling W, Schulz H, et al. 2005. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect. 113:1555–1560.
   PubMed Web of Science ®Google Scholar
• Gelperina SE, Khalansky AS, Skidan IN, Smirnova ZS, Bobruskin AI, Severin SE, et al. 2002. Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma. Toxicol Lett. 126:131–141.
   PubMed Web of Science ®Google Scholar
• Gessner A, Lieske A, Paulke BR, Müller RH. 2002. Influence of surface charge density on protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis. Eur J Pharm Biopharm. 54:165–170.
   PubMed Web of Science ®Google Scholar
• Goppert TM, Muller RH. 2005. Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN). Eur J Pharm Biopharm. 60:361–372.
   PubMed Web of Science ®Google Scholar
• Gref R, Lück M, Quellec P, Marchand M, Dellacherie E, Harnisch S, Blunk T, Müller R. 2000. ‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloid Surface B. 18:301–313.
   PubMed Web of Science ®Google Scholar
• Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R. 1994. Biodegradable long-circulating polymeric nanospheres. Science. 263:1600–1603.
   PubMed Web of Science ®Google Scholar
• Gu Y-J, Cheng J, Lin C-C, Lam YW, Cheng SH, Wong W-T. 2009. Nuclear penetration of surface functionalized gold nanoparticles. Toxicol Appl Pharmacol. 237:196–204.
   PubMed Web of Science ®Google Scholar
• Gulyaev AE, Gelperina SE, Skidan IN, Antropov AS, Kivman GY, Kreuter J. 1999. Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles. Pharm Res. 16:1564–1569.
   PubMed Web of Science ®Google Scholar
• Hallock MF, Greenley P, DiBerardinis L, Kallin D. 2009. Potential risks of nanomaterials and how to safely handle materials of uncertain toxicity. JCHAS. 16:16–23.
   Google Scholar
• Harris TJ, Green JJ, Fung PW, Langer R, Anderson DG, Bhatia SN. 2010. Tissue-specific gene delivery via nanoparticle coating. Biomaterials. 31:998–1006.
   PubMed Web of Science ®Google Scholar
• He C, Hu Y, Yin L, Tang C, Yin C. 2010. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials. 31:3657–3666.
   PubMed Web of Science ®Google Scholar
• Hillaireau H, Couvreur P. 2009. Nanocarriers' entry into the cell: relevance to drug delivery. Cell Mol Life Sci.66:2873–2896.
   PubMed Web of Science ®Google Scholar
• Hillyer JF, Albrecht RM. 2001. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J Pharm Sci. 90:1927–1936.
   PubMed Web of Science ®Google Scholar
• Hoet PHM, Brüske-Hohlfeld I, Salata OV. 2004. Nanoparticles – known and unknown health risks. J Nanobiotechnol. 2:12–27.
   PubMedGoogle Scholar
• Hoffman AJ, Carraway ER, Hoffmann MR. 1994. Photocatalytic production of H2O2 and organic peroxides on quantum-sized semiconductor colloids. Environ Sci Technol. 28:776–785.
   PubMed Web of Science ®Google Scholar
• Hsiao I-L, Huang Y-J. 2011. Effects of various physicochemical characteristics on the toxicities of ZnO and TiO nanoparticles toward human lung epithelial cells. Sci Total Environ. 409:1219–1228.
   PubMed Web of Science ®Google Scholar
• Hsu S-h, Lin Z-C. 2004. Biocompatibility and biostability of a series of poly(carbonate)urethanes. Colloids Surf B Biointerfaces. 36:1–12.
   PubMed Web of Science ®Google Scholar
• Isakovic A, Markovic Z, Todorovic-Markovic B, Nikolic N, Vranjes-Djuric S, Mirkovic M, et al. 2006. Distinct cytotoxic mechanisms of pristine versus hydroxylated fullerene. Toxicol Sci. 91:173–183.
   PubMed Web of Science ®Google Scholar
• Ji ZQ, Sun H, Wang H, Xie Q, Liu Y, Wang Z. 2006. Biodistribution and tumor uptake of C60 (OH) x in mice. J Nanopart Res. 8:53–63.
   Web of Science ®Google Scholar
• Jokerst JV, Lobovkina T, Zare RN, Gambhir SS. 2011. Nanoparticle PEGylation for imaging and therapy. Nanomedicine (Lond). 6:715–728.
   PubMed Web of Science ®Google Scholar
• Kamali M, Dinarvand R, Maleki H, Arzani H, Mahdaviani P, Nekounam H, Adabi M, Khosravani M. 2015. Preparation of imatinib base loaded human serum albumin for application in the treatment of glioblastoma. RSC Adv. 5:62214–62219.
   Web of Science ®Google Scholar
• Kang S, Herzberg M, Rodrigues DF, Elimelech M. 2008. Antibacterial effects of carbon nanotubes: size does matter!. Langmuir. 24:6409–6413.
   PubMed Web of Science ®Google Scholar
• Karimi MA, Pourhakkak P, Adabi M, Firoozi S, Adabi M, Naghibzadeh M. 2015. Using an artificial neural network for the evaluation of the parameters controlling PVA/chitosan electrospun nanofibers diameter. e-Polymers. 15:127–138.
   Web of Science ®Google Scholar
• Karmali PP, Simberg D. 2011. Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems. Expert Opin Drug Deliv. 8:343–357.
   PubMed Web of Science ®Google Scholar
• Kedmi R, Ben-Arie N, Peer D. 2010The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation. Biomaterials. 31:6867–6875.
   PubMed Web of Science ®Google Scholar
• Ketabchi N, Naghibzadeh M, Adabi M, Esnaashari SS, Faridi-Majidi R. 2016. Preparation and optimization of chitosan/polyethylene oxide nanofiber diameter using artificial neural networks. Neural Comput Appl. [Epub ahead of print]. DOI: 10.1007/s00521-016-2212-0.
   Web of Science ®Google Scholar
• Kim HR, Andrieux K, Delomenie C, Chacun H, Appel M, Desmaële D, et al. 2007. Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2-DE, CE and Protein Lab-on-chip system. Electrophoresis. 28:2252–2261.
   PubMed Web of Science ®Google Scholar
• Kim SY, Nishioka M, Taya M. 2004. Promoted proliferation of an SOD-deficient mutant of Escherichia coli under oxidative stress induced by photoexcited TiO2. FEMS Microbiol Lett. 236:109–114.
   PubMed Web of Science ®Google Scholar
• Kiwada H, Miyajima T, Kato Y. 1987. Studies on the uptake mechanism of liposomes by perfused rat liver. II. An indispensable factor for liver uptake in serum. Chem Pharm Bull. 35:1189–1195.
   PubMed Web of Science ®Google Scholar
• Kunzmann A, Andersson B, Thurnherr T, Krug H, Scheynius A, Fadeel B. 2011. Toxicology of engineered nanomaterials: focus on biocompatibility, biodistribution and biodegradation. Biochim Biophys Acta. 1810:361–373.
   PubMed Web of Science ®Google Scholar
• La Francesca S. 2012. Nanotechnology and stem cell therapy for cardiovascular diseases: potential applications. Methodist DeBakey Cardiovasc J. 8:28–35.
   PubMedGoogle Scholar
• Lemarchand C, Gref R, Passirani C, Garcion E, Petri B, Müller R, Costantini D, Couvreur P. 2006. Influence of polysaccharide coating on the interactions of nanoparticles with biological systems. Biomaterials. 27:108–118.
   PubMed Web of Science ®Google Scholar
• Levine BR, Sporer S, Poggie RA, Della Valle CJ, Jacobs JJ. 2006. Experimental and clinical performance of porous tantalum in orthopedic surgery. Biomaterials. 27:4671–4681.
   PubMed Web of Science ®Google Scholar
• Lin I, Liang M, Liu T-Y, Jia Z, Monteiro MJ, Toth I. 2012. Effect of polymer grafting density on silica nanoparticle toxicity. Bioorgan Med Chem. 20:6862–6869.
   PubMed Web of Science ®Google Scholar
• Linkov I, Satterstrom FK, Corey LM. 2008. Nanotoxicology and nanomedicine: making hard decisions. Nanomedicine. 4:167–171.
   PubMed Web of Science ®Google Scholar
• Liu H, Webster TJ. 2007. Nanomedicine for implants: a review of studies and necessary experimental tools. Biomaterials. 28:354–369.
   PubMed Web of Science ®Google Scholar
• Lynch I, Dawson KA. 2008. Protein-nanoparticle interactions. Nano Today. 3:40–47.
   Web of Science ®Google Scholar
• Maffre P, Nienhaus K, Amin F, Parak WJ, Nienhaus GU. 2011. Characterization of protein adsorption onto FePt nanoparticles using dual-focus fluorescence correlation spectroscopy. Beilstein J Nanotechnol. 2:374–383.
   PubMed Web of Science ®Google Scholar
• Martin I, Wendt D, Heberer M. 2004. The role of bioreactors in tissue engineering. Trends Biotechnol. 22:80–86.
   PubMed Web of Science ®Google Scholar
• Moghimi S. 2002. Chemical camouflage of nanospheres with a poorly reactive surface: towards development of stealth and target-specific nanocarriers. Biochim Biophys Acta. 1590:131–139.
   PubMed Web of Science ®Google Scholar
• Moghimi SM. 2003. Modulation of lymphatic distribution of subcutaneously injected poloxamer 407-coated nanospheres: the effect of the ethylene oxide chain configuration. FEBS Lett. 540:241–244.
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Hunter AC, Murray JC. 2001. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev. 53:283–318.
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Szebeni J. 2003. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res. 42:463–478.
   PubMed Web of Science ®Google Scholar
• Mohanraj V, Chen Y. 2007. Nanoparticles – a review. Trop J Pharm Res. 5:561–573.
   Google Scholar
• Müller R, Wallis K, Tröster S, Kreuter J. 1992. In vitro characterization of poly (methyl-methaerylate) nanoparticles and correlation to their in vivo fate. J Control Release. 20:237–246.
   Web of Science ®Google Scholar
• Naghibzadeh M, Adabi M. 2014. Evaluation of effective electrospinning parameters controlling gelatin nanofibers diameter via modelling artificial neural networks. Fibers Polym. 15:767–777.
   Web of Science ®Google Scholar
• Nel AE, Mädler L, Velegol D, Xia T, Hoek EM, Somasundaran P, et al. 2009. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater. 8:543–557.
   PubMed Web of Science ®Google Scholar
• Nemmar A, Hoylaerts MF, Hoet PHM, Dinsdale D, Smith T, Xu H, Vermylen J, Nemery B. 2002. Ultrafine particles affect experimental thrombosis in an in vivo hamster model. Am J Respir Crit Care Med. 166:998–1004.
   PubMed Web of Science ®Google Scholar
• Norman M, Williams P, Illum L. 1992. Human serum albumin as a probe for surface conditioning (opsonization) of block copolymer-coated microspheres. Biomaterials. 13:841–849.
   PubMed Web of Science ®Google Scholar
• Oberdörster G. 2002. Toxicokinetics and effects of fibrous and nonfibrous particles. Inhal Toxicol. 14:29–56.
   PubMed Web of Science ®Google Scholar
• Oberdörster G, Ferin J, Lehnert BE. 1994. Correlation between particle size, in vivo particle persistence, and lung injury. Environ Health Persp. 102:173–179.
   PubMed Web of Science ®Google Scholar
• Oberdürster G. 2000. Toxicology of ultrafine particles: in vivo studies. Philos T Roy Soc A. 358:2719–2740.
   Web of Science ®Google Scholar
• Owens Iii DE, Peppas NA. 2006. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm. 307:93–102.
   PubMed Web of Science ®Google Scholar
• Paciotti GF, Myer L, Weinreich D, Goia D, Pavel N, McLaughlin RE, Tamarkin L. 2004. Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv. 11:169–183.
   PubMed Web of Science ®Google Scholar
• Pan Y, Leifert A, Ruau D, Neuss S, Bornemann J, Schmid G, et al. 2009. Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. Small. 5:2067–2076.
   PubMed Web of Science ®Google Scholar
• Panyam J, Labhasetwar V. 2003. Dynamics of endocytosis and exocytosis of poly(D,L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells. Pharm Res. 20:212–220.
   PubMed Web of Science ®Google Scholar
• Pardridge WM. 1992. Recent developments in peptide drug delivery to the brain. Pharmacol. Toxicol. 71:3–10.
   PubMedGoogle Scholar
• Pardridge WM. 1998. CNS drug design based on principles of blood-brain barrier transport . J. Neurochem. 70:1781–1792.
   PubMed Web of Science ®Google Scholar
• Park MV, Neigh AM, Vermeulen JP, de la Fonteyne LJ, Verharen HW, Briedé JJ, van Loveren H, de Jong WH. 2011. The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles. Biomaterials. 32:9810–9817.
   PubMed Web of Science ®Google Scholar
• Patel H. 1992. Serum opsonins and liposomes: their interaction and opsonophagocytosis. Crit Rev Ther Drug Carrier Syst. 9:39–90
   PubMed Web of Science ®Google Scholar
• Patil S, Sandberg A, Heckert E, Self W, Seal S. 2007. Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential. Biomaterials. 28:4600–4607.
   PubMed Web of Science ®Google Scholar
• Peracchia M, Fattal E, Desmaele D, Besnard M, Noel J, Gomis J, et al. 1999a. Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting. J Control Release. 60:121–128.
   PubMed Web of Science ®Google Scholar
• Peracchia M, Harnisch S, Pinto-Alphandary H, Gulik A, Dedieu J, Desmaele D, et al. 1999b. Visualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticles. Biomaterials. 20:1269–1275.
   PubMed Web of Science ®Google Scholar
• Pereverzeva E, Treschalin I, Bodyagin D, Maksimenko O, Langer K, Dreis S, et al. 2007. Influence of the formulation on the tolerance profile of nanoparticle-bound doxorubicin in healthy rats: focus on cardio- and testicular toxicity . Int J Pharm. 337:346–356.
   PubMed Web of Science ®Google Scholar
• Ramalingam M, Rana D. 2015. Impact of nanotechnology in induced pluripotent stem cells-driven tissue engineering and regenerative medicine. J Bionanosci. 9:13–21.
   Google Scholar
• Ran F, Nie S, Zhao W, Li J, Su B, Sun S, Zhao C. 2011. Biocompatibility of modified polyethersulfone membranes by blending an amphiphilic triblock co-polymer of poly(vinyl pyrrolidone)-b-poly(methyl methacrylate)-b-poly(vinyl pyrrolidone). Acta Biomater. 7:3370–3381.
   PubMed Web of Science ®Google Scholar
• Reddy ARN, Reddy YN, Krishna DR, Himabindu V. 2010. Multi wall carbon nanotubes induce oxidative stress and cytotoxicity in human embryonic kidney (HEK293) cells. Toxicology. 272:11–16.
   PubMed Web of Science ®Google Scholar
• Reddy ST, Rehor A, Schmoekel HG, Hubbell JA, Swartz MA. 2006. In vivo targeting of dendritic cells in lymph nodes with poly (propylene sulfide) nanoparticles. J Control Release. 112:26–34.
   PubMed Web of Science ®Google Scholar
• Reese TS, Karnovsky MJ. 1967. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol. 34:207–217.
   PubMed Web of Science ®Google Scholar
• Roser M, Fischer D, Kissel T. 1998. Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats. Eur J Pharm Biopharm. 46:255–263.
   PubMed Web of Science ®Google Scholar
• Rothen-Rutishauser BM, Schürch S, Haenni B, Kapp N, Gehr P. 2006. Interaction of fine particles and nanoparticles with red blood cells visualized with advanced microscopic techniques. Environ Sci Technol. 40:4353–4359.
   PubMed Web of Science ®Google Scholar
• Sadaf A, Zeshan B, Wang Z, Zhang R, Xu S, Wang C, Cui Y. 2012. Toxicity evaluation of hydrophilic CdTe quantum dots and CdTe@SiO2 nanoparticles in mice. J Nanosci Nanotechnol. 12:8287–8292.
   PubMed Web of Science ®Google Scholar
• Sahoo B, Goswami M, Nag S, Maiti S. 2007. Spontaneous formation of a protein corona prevents the loss of quantum dot fluorescence in physiological buffers. Chem Phys Lett. 445:217–220.
   Web of Science ®Google Scholar
• Sarin H, Kanevsky AS, Wu H, Brimacombe KR, Fung SH, Sousa AA, et al. 2008. Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells. J Transl Med. 6:80–95.
   PubMed Web of Science ®Google Scholar
• Sarvestani AS, He X, Jabbari E. 2007. Effect of osteonectin-derived peptide on the viscoelasticity of hydrogel/apatite nanocomposite scaffolds. Biopolymers. 85:370–378.
   PubMed Web of Science ®Google Scholar
• Shakoori Z, Salimian S, Kharrazi S, Adabi M, Saber R. 2015. Electrochemical DNA biosensor based on gold nanorods for detecting hepatitis B virus. Analyt Bioanalyt Chem. 407:455–461.
   PubMed Web of Science ®Google Scholar
• Shi J, Xu B, Sun X, Ma C, Yu C, Zhang H. 2013. Light induced toxicity reduction of silver nanoparticles to Tetrahymena Pyriformis: effect of particle size. Aquat Toxicol. 132–133:53–60.
   PubMed Web of Science ®Google Scholar
• Singh S, Shi T, Duffin R, Albrecht C, van Berlo D, Höhr D, et al. 2007. Endocytosis, oxidative stress and IL-8 expression in human lung epithelial cells upon treatment with fine and ultrafine TiO2: role of the specific surface area and of surface methylation of the particles. Toxicol Appl Pharm. 222:141–151.
   PubMed Web of Science ®Google Scholar
• Suh WH, Suslick KS, Stucky GD, Suh Y-H. 2009. Nanotechnology, nanotoxicology, and neuroscience. Prog Neurobiol. 87:133–170.
   PubMed Web of Science ®Google Scholar
• Sun J, Dai Z, Zhao Y, Chen G-Q. 2007. In vitro effect of oligo-hydroxyalkanoates on the growth of mouse fibroblast cell line L929. Biomaterials. 28:3896–3903.
   PubMed Web of Science ®Google Scholar
• Sun L, Li Y, Liu X, Jin M, Zhang L, Du Z, et al. 2011. Cytotoxicity and mitochondrial damage caused by silica nanoparticles. Toxicol In Vitro. 25:1619–1629.
   PubMed Web of Science ®Google Scholar
• Tavakol S, Nikpour MR, Hoveizi E, Tavakol B, Rezayat SM, Adabi M, Abokheili SS, Jahanshahi M. 2014. Investigating the effects of particle size and chemical structure on cytotoxicity and bacteriostatic potential of nano hydroxyapatite/chitosan/silica and nano hydroxyapatite/chitosan/silver; as antibacterial bone substitutes. J Nanopart Res. 16:2622–2635.
   Web of Science ®Google Scholar
• Thi Ha Lien N, Thi Tuyen N, Emmanuel F, Thanh Phuong N, Thi My Nhung H, Thi Quy N, Hong Nhung T. 2012. Capping and in vivo toxicity studies of gold nanoparticles. Adv Nat Sci Nanosci Nanotechnol. 3:015002–015007.
   Google Scholar
• Tiwari DK, Jin T, Behari J. 2011. Dose-dependent in vivo toxicity assessment of silver nanoparticle in Wistar rats. Toxicol Mech Methods. 21:13–24.
   PubMed Web of Science ®Google Scholar
• Tiwari SB, Amiji MM. 2006. A review of nanocarrier-based CNS delivery systems. Curr Drug Deliv. 3:219–232.
   PubMedGoogle Scholar
• Triguero D, Buciak J, Pardridge WM. 1990. Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins. J Neurochem. 54:1882–1888.
   PubMed Web of Science ®Google Scholar
• Tröster SD, Müller U, Kreuter J. 1990. Modification of the body distribution of poly (methyl methacrylate) nanoparticles in rats by coating with surfactants. Int J Pharm. 61:85–100.
   Web of Science ®Google Scholar
• Tsai C-C, Chang Y, Sung H-W, Hsu J-C, Chen C-N. 2001. Effects of heparin immobilization on the surface characteristics of a biological tissue fixed with a naturally occurring crosslinking agent (genipin): an in vitro study. Biomaterials. 22:523–533.
   PubMed Web of Science ®Google Scholar
• Tyrrell DA, Richardson VJ, Ryman BE. 1977. The effect of serum protein fractions on liposome-cell interactions in cultured cells and the perfused rat liver. Biochim Biophys Acta. 497:469–480.
   PubMed Web of Science ®Google Scholar
• Wang S, Lu W, Tovmachenko O, Rai US, Yu H, Ray PC. 2008. Challenge in understanding size and shape dependent toxicity of gold nanomaterials in human skin keratinocytes. Chem Phys Lett. 463:145–149.
   PubMed Web of Science ®Google Scholar
• Wigfield C, Robertson J, Gill S, Nelson R. 2003. Clinical experience with porous tantalum cervical interbody implants in a prospective randomized controlled trial. Br J Neurosurg. 17:418–425.
   PubMed Web of Science ®Google Scholar
• Williams D. 1989. A model for biocompatibility and its evaluation. J Biomed Eng. 11:185–191.
   PubMedGoogle Scholar
• Wolburg H, Lippoldt A. 2002. Tight junctions of the blood-brain barrier: development, composition and regulation. Vasc Pharmacol. 38:323–337.
   PubMed Web of Science ®Google Scholar
• Wu D, Pardridge WM. 1998. Pharmacokinetics and blood-brain barrier transport of an anti-transferrin receptor monoclonal antibody (OX26) in rats after chronic treatment with the antibody. Drug Metab Dispos. 26:937–939.
   PubMed Web of Science ®Google Scholar
• Yan A, Lau BW, Weissman BS, Külaots I, Yang NYC, Kane AB, Hurt RH. 2006. Biocompatible, hydrophilic, supramolecular carbon nanoparticles for cell delivery. Adv Mater. 18:2373–2378.
   Web of Science ®Google Scholar
• Yang H, Liu C, Yang D, Zhang H, Xi Z. 2009. Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition. J Appl Toxicol. 29:69–78.
   PubMed Web of Science ®Google Scholar
• Yang Y, Leong KW. 2010. Nanoscale surfacing for regenerative medicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2:478–495.
   PubMed Web of Science ®Google Scholar
• Zhang X-D, Wu H-Y, Wu D, Wang Y-Y, Chang J-H, Zhai Z-B, et al. 2010. Toxicologic effects of gold nanoparticles in vivo by different administration routes. Int J Nanomedicine. 5:771–781.
   PubMed Web of Science ®Google Scholar
• Zhu Z-J, Carboni R, Quercio MJ, Yan B, Miranda OR, Anderton DL, et al. 2010. Surface properties dictate uptake, distribution, excretion, and toxicity of nanoparticles in fish. Small. 6:2261–2265.
   PubMed Web of Science ®Google Scholar
• Zolnik BS, González-Fernández Á, Sadrieh N, Dobrovolskaia MA. 2010. Minireview: nanoparticles and the immune system. Endocrinology. 151:458–465.
   PubMed Web of Science ®Google Scholar